Abstract:
PROBLEM TO BE SOLVED: To provide a method for etching material at its surface by a focused electronic beam for deriving a chemical reaction on the surface. SOLUTION: The method comprises irradiating the material to be etched by using at least one molecular beam, at least one photon beam and at least one electronic beam in a vacuum atmosphere, exciting the irradiated material and the molecules of the molecular beam so as to induce the prescribed chemical reaction by the compositions of the material and the molecules and to form a reaction product, and removing the reaction product from the surface of the material, i.e., having irradiating and removing steps. COPYRIGHT: (C)2004,JPO
Abstract:
Disclosed herein is a system and method for generating a motion-corrected 2D image of a target. The method comprises acquiring a 3D static image of the target before an interventional procedure. During the procedure, a number of 2D real time images of the target are acquired and displayed. A slice of the 3D static image is acquired and registered with one 2D real time image and then the location of the 3D static image is corrected to be in synchrony with body motion. The motion corrected 2D image of the target is then displayed.
Abstract:
A mechanical tracking system comprises a first set of linkage arms, a second set of linkage arms, a pair of shafts connected at first end to one arm of the first set of linkage arms and at a second end to one arms of said second set of the linkage arms, wherein each arm of the second set of linkage arms is oriented out of phase with a respective arm of the first set of linkage arms, an attachment shaft positioned adjacent to the first set of linkage arms to accommodate a tool, and a sensor arrangement configured lo sense the orientation and position of the attachment shaft.
Abstract:
A method of producing a hydrolyzed fermented medium containing microorganisms such as bacteria or yeast and the products of their metabolism in high concentration, the method includes providing at least one solid plant product reduced to small pieces and mixed with sugar and a biocompatible liquid such as milk for fermentation at a temperature of between 35 and 58 degrees C until the acidity of the medium reaches the range of 300 to 900 in Terner degrees. In an alternative embodiment, the medium is prepared by mixing in predetermined amounts of sprouted grains, biocompatible liquid inoculated with at least one of a variety of non-pathogenic microorganisms, vegetables, fruits, berries, high protein products, herbs, sugar, and a chemical element such as potassium. The mixture is then fermented at a selected temperature for a specified length of time to reach high acidity and high concentration of products of bacterial metabolism. A liquid phase is separated from a solid sediment phase and can be used to treat a wide variety of diseases including HIV/AIDS, viral infections, cardiovascular diseases, Alzheimer's and others as well as for other applications.
Abstract:
The present invention is used in conjunction with a multi-channel system of a production string for deployment in gas, condensate or oil wells. An end-piece is placed at the entrance to such multi--channel system. It includes a semi-enclosed space helping to increase the proportion of gas phase entering the system at its bottom entrance. Increased proportion of gas allows lifting liquids and/or solids from the wellbore with greater efficiency. Examples of using the invention include wellbore water removal for gas wells with liquid loading problems, for solution gas drive or gas cap driven oils wells during their initial "natural flowing phase", or during gas re-injection or gas-lift recovery operations for oil wells. It can also be used for gas-lifting water in water wells.
Abstract:
A substance with sedative effect comprises a therapeutically effective amoun t of a gamma-pyrone such as comenic acid, meconic acid, chelidonic acid, and alike in a pharmaceutically acceptable carrier. When administered at a daily dosage of between 5 and 200 mg of active ingredient per kilogram of a body weight of a patient, the substance can be used to treat various neurotic disorders such as insomnia, anxiety, neurosis, depression as well as withdrawal symptoms for drug addiction patients, especially for patients addicted to opioid-based drugs. The substance can be delivered in a number o f ways of systemic administration of a pharmaceutical agent including oral, parenteral, transdermal, and transmucosal administration. For drug addicted patients, the preferred method of administration involves a subcutaneous implant providing a continuous release of an active ingredient at an effecti ve daily rate over the entire treatment period ranging from 5 to 30 days, and preferably from 13 to 20 days.
Abstract:
A method for treating a vaginal disease by applying a hydrolyzed product in a variety of ways including preferably intravaginal, as well as oral, rectal, or transcutaneous administration, inhalation, intravenous or intraperitoneal injection. The product is produced by providing at least one solid plant product reduced to small pieces and mixed with sugar and a biocompatible liquid for fermentation at a temperature of between 15 and 55 degrees C. until its acidity reaches the range of 300 to 900 Terner degrees. Alternatively, the product is prepared by mixing in predetermined amounts of sprouted grains, biocompatible liquid inoculated with at least one from a variety of non-pathogenic microorganisms, vegetables, fruits, berries, high protein products, herbs, sugar, and a chemical element such as potassium. The mixture is then fermented at a selected temperature for a specified length of time to reach high acidity and high concentration of products of bacterial metabolism. This invention relates to a hydrolyzed medium used for the prevention of and treatment for urogenital infections, cancer and endometriosis.
Abstract:
A substance with sedative effect comprises a therapeutically effective amount of a gamma-pyrone such as comenic acid in a pharmaceutically acceptable carrier. When administered at a daily dosage of between 0.05 mg to about 10,000 mg of active ingredient per unit dose, the substance can be used to treat various disorders of a nervous system such as pain, insomnia, anxiety, neurosis, depression, as well as withdrawal symptoms experienced by drug addiction patients, especially for patients addicted to opiate-based drugs. The substance can be delivered in a number of ways of systemic administration of a pharmaceutical agent including oral, parenteral, transdermal, and transmucosal administration. One disclosed method of administration involves a subcutaneous implant providing a continuous release of an active ingredient at an effective daily rate over the entire treatment period ranging from 5 to 30 days, and preferably from 13 to 20 days.
Abstract:
A piezoelectric sheet conveying device of a linear contact type contains a pair of rollers containing the sheet therebetween. The first roller is driven by a piezoelectric vibrator forming a contact line between the edge insert of the vibrator and the outer surface of the first roller. The vibrator is urged against the first roller by a bias spring. The hardness of the edge insert of the vibrator is about 5x107 N/cm2 and much higher than the hardness of the first roller being about 2x106 N/cm2. As a result, elastic compressions of the first roller are achieved during periodic elongations of the vibrator and engagements of the first roller surface. Microgroove is formed along the contact line between the vibrator and the first roller which transmits the rotational torque to the first roller and advances the sheet in a predetermined direction. Subsequent contraction of the vibrator restores the outer surface of the first roller to its initial shape. Both the first roller and the vibrator can be made as laminated structures to achieve respectively correct composite hardness and reduce the driving voltage.